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Abstract
The recent finding of a new mecA homologue, mecALGA251, with only 70% nucleotide homology to the conventional mecA gene has
brought the routine testing for mecA as a confirmatory test for methicillin-resistant Staphylococcus aureus (MRSA) into question. A multi-
plex PCR was designed to differentiate mecALGA251 from the known mecA together with detection of lukF-PV and the spa gene fragments,
enabling direct spa typing by sequencing of the PCR amplicons. The PCR analysis and subsequent spa typing were validated on a large
collection (n = 185) of contemporary MRSA and methicillin-sensitive S. aureus isolates, including 127 isolates carrying mecALGA251. The
mecALGA251 gene was situated in staphylococcal cassette chromosome mec type XI elements, and sequence variation within a 631-bp
fragment of mecALGA251 in 79 isolates indicated a very conserved gene sequence. Following a successful validation, the multiplex PCR
strategy was implemented in the routine testing of MRSA for national surveillance. Over a 2-month period, among 203 samples tested,
12 new MRSA cases caused by isolates carrying mecALGA251 were identified, emphasizing the clinical importance of testing for these new
MRSA isolates.
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Introduction
Following its emergence in the 1960s, methicillin-resistant
Staphylococcus aureus (MRSA) has been a major threat, first
to hospitalized patients, but also, over the last decade,
increasingly to patients outside healthcare facilities, owing to
community-associated MRSA. Since its discovery, detection
of the mecA gene encoding penicillin-binding protein 2a,
which confers resistance to all b-lactams, has been the refer-
ence standard for detection of MRSA. A novel mecA homo-
logue (mecALGA251) was recently reported. It has been found
in S. aureus lineages typically associated with cattle, i.e. clonal
complex (CC)130, CC1943, and sequence type 425 [1]. The
mecALGA251 gene shares only 70% nucleotide homology with
mecA, and is found in a novel staphylococcal cassette chro-
mosome (SCC) element designated SCCmec type XI. Thus
far, isolates containing mecALGA251 have proved to be resis-
tant phenotypically to b-lactams, but have failed to be recog-
nized as ‘classical’ MRSA with conventional PCRs for mecA,
owing to the different nucleotide composition [1,2]. The ini-
tial detection method for mecALGA251 was a non-discrimina-
tory PCR co-detecting both mecA and mecALGA251 with the
same amplicon length, requiring an additional conventional
mecA PCR to distinguish the mecALGA251 genotype, making
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the method less useful for reference laboratory use [3]. Spe-
cific primers for mecALGA251 were recently tested on 11
CC130 isolates from Germany, indicating the need for a spe-
cific method for detection of mecALGA251 in a single PCR
reaction [4]. The National Staphylococcus Laboratory at Sta-
tens Serum Institut (SSI) holds two major S. aureus strain
collections: (i) all Danish MRSA or suspected MRSA isolates
found since 1988; and (ii) all Danish S. aureus bacteraemia
isolates found since 1958. All isolates have been typed using
different methods (phage typing, pulsed-field gel electropho-
resis, and/or spa typing), and all MRSA isolates have been
confirmed by mecA detection, providing a valuable archive
from which putative mecALGA251-positive isolates can be
retrieved. All isolates submitted after November 2006 have
been subjected to a triplex PCR detecting mecA, spa, and lukF-
PV, with subsequent sequencing of the spa amplicons [5]. To
facilitate rapid detection and characterization of isolates
harbouring mecALGA251, the triplex PCR has been expanded to
include mecALGA251-specific primers. Herein, we report the
design, validation and utility of the revised assay with a large
(n = 185) and diverse set of both MRSA and methicillin-
sensitive S. aureus (MSSA) isolates, including 127 mecALGA251-
positive isolates. The mecALGA251-positive isolates were
investigated in detail, including spa typing, partial analysis of
SCCmec, and nucleotide variation in the mecALGA251
sequence.
Materials and Methods
Search strategy
Danish S. aureus isolates from 1975 onwards were selected
for this study on the basis of: (i) possession of spa types
identical or similar to those previously reported in
mecALGA251-positive isolates (t742, t843, t978, t1535, t1736,
t6220, t6292, t6293, t6300, t6386, t7485, t7734, t7945,
t7946, or t7947); or (ii) possession of an MRSA phenotype
but negative results for mecA with conventional PCR [1].
These isolates, together with 148 mecA-negative isolates with
other spa types having cefoxitin zone diameters just above
the set breakpoint for MRSA detection with disk diffusion
antimicrobial susceptibility testing (MSSA), were subjected to
mecA/mecALGA251 PCR as described by Garcia-Alvarez et al.
[1].
Isolate characterization
All mecA-negative and mecALGA251-positive isolates identified
were spa-typed, and subjected to multilocus sequence typing
(MLST) if new spa types, not previously associated with
CC130 or CC1943 isolates, were found [6].
mecALGA251 detection and characterization
The primer sequences used in this study are listed in
Table 1. All amplifications were performed on supernatants
from crude DNA extracts; 1 lL of bacteria boiled in 300 lL
of dH2O for 5 min and subsequently centrifuged for 5 min at
13 000 g. Initially, degenerate primers for mecA/mecALGA251
were used to verify the presence of mecALGA251 in all 127
mecA-negative isolates, as previously described [1]. Novel
primers (mecALGA251MultiFP and mecALGA251MultiRP) discrimi-
nating mecALGA251 (138 bp) from mecA (162 bp) were
designed on the basis of the sequence of LGA251 (accession
no. FR821779), and were implemented in a triplex PCR
detecting spa, mecA, and lukF-PV [5]. Briefly, 0.4 lM of each
primer was added to a Qiagen Multiplex PCR Master kit
(Qiagen, Valencia, CA, USA), and amplification was
TABLE 1. Primers used in this study to detect and characterize mecALGA251 and SCCmec
Primer names Gene Sequence (5¢–3¢) Amplicon size (bp) References
mecA P4 mecA TCCAGATTACAACTTCACCAGG 162 [11]
mecA P7 CCACTTCATATCTTGTAACG
spa-1113f spa TAAAGACGATCCTTCGGTGAGC Variable (180–600) [12]
spa-1514r CAGCAGTAGTGCCGTTTGCTT
pvl-FP lukF-PV GCTGGACAAAACTTCTTGGAATAT 83 [13]
pvl-RP GATAGGACACCAATAAATTCTGGATTG
mecALGA251FP mecALGA251 TCACCAGGTTCAAC[Y]CAAAA 356 [4]
mecALGA251RP CCTGAATC[W]GCTAATAATATTTC
mecALGA251MultiFP mecALGA251 GAAAAAAAGGCTTAGAACGCCTC 718 This study, [4]
mecALGA251RP CCTGAATC[W]GCTAATAATATTTC
mecALGA251MultiFP mecALGA251 GAAAAAAAGGCTTAGAACGCCTC 138 This study
mecALGA251MultiRP GAAGATCTTTTCCGTTTTCAGC
mecIF mecI GACACGTGAAGGCTATGATATAT 344 [4]
mecIR ATTCTTCAATATCATCTTCGGAC
mecR1F mecR1 GGCTCAGTTAAATCATAAAGTTTG 710 [4]
mecR1R AAATTGCCTTACCATAGCTTGTGT
ccrAF ccrA1 GCAATAGGTTATCTACGTCAAAG 932 [4]
ccrAR TCTAATGATTGTGCGTTGATTCC
ccrBF ccrB3 TTCGTGTATCGACAGAAATGCAG 1449 [4]
ccrBR CATCTTTACGAATATCAATACGG
blaZF blaZ AGTCGTGTTAGCGTTGATATTAA, 809 [4]
blaZR CAATTTCAGCAACCTCACTTACTA
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performed with the following program: 15 min at 94C, fol-
lowed by 30 cycles of 30 s at 94C, 1 min at 59C, and
1 min at 72C, with a final 10 min elongation step at 72C.
PCR products were visualized on 2% E-Gels (Invitrogen,
Grand Island, CA, USA).
Validation of the PCR was performed on 127 mecA-nega-
tive, mecALGA251-positive isolates, originating from Denmark
(n = 84), England (n = 28), Scotland (n = 12), and France
(n = 3); of these, 28 English isolates (13 human and 15
bovine), 12 Scottish and 24 Danish isolates (all human, spa
type t843) have been described previously [1]. Also included
were 20 MSSA isolates (t002, t012, t015, t021, t065, t084,
t091, t127, t216, and t230) and 30 MRSA isolates (t002,
t008, t019, t024, t032, t034, t041, t044, t127, and t437) rep-
resenting the predominant spa types found in Denmark in
2009 and 2010, respectively, as well as isolates representing
SCCmec types I–VI, IX and X [7,8].
Routine testing with the new multiplex PCR
From 1 August 2011, the new multiplex PCR was imple-
mented as a routine test and applied to a total of 203 sus-
pected MRSA isolates submitted from all 15 Danish Clinical
Microbiological Departments.
mecALGA251 sequence variation and SCCmec characterization
To search for evidence of sequence variation, amplification of
a 720-bp fragment of mecALGA251 was performed with 79 iso-
lates (England (n = 9), France (n = 3), and Denmark (n = 67)),
representing CC130, CC425, and CC1943. PCR was per-
formed with 0.4 lM of each primer (mecALGA251MultiFP and
mecALGA251RP), 2 mM MgCl2 and the Qiagen Multiplex PCR
Master kit, with the following program: 15 min at 94C, fol-
lowed by 35 cycles of 30 s at 94C, 1 min at 50C, and 1 min
at 72C, with a final 10 min elongation step at 72C. DNA
sequencing was performed by GATC-Biotech (Konstanz, Ger-
many). Sequences were analysed with the CLC Genomics
workbench 4.7.2 software (CLC bio, Aarhus, Denmark).
The SCC element was characterized with three PCRs to
detect mecI/mecR1, ccrA/B and blaZ, with the SCCmec
type XI element defined as described by Garcia-Alvarez et al.
[1]. All mecALGA251-positive isolates that were negative for
ccrA and/or ccrB, as described above, were subjected to mul-
tiplex PCR for detection of other known ccr alleles [9].
Results
Searches
Investigation of the collections at SSI for isolates with spa
types identical or similar to the previously reported types
associated with mecALGA251, or for isolates that were MRSA
phenotypically but mecA-negative, revealed 84 isolates from
individual patients. Of these, 40 were cefoxitin-resistant but
mecA-negative; the remaining 44 (also cefoxitin-resistant)
were identified primarily on the basis of their spa types,
which were related to those associated with carriage of
mecALGA251 previously.
Except for two bacteraemia isolates from 1975 (t843) and
1992 (t9397), all Danish isolates were recovered in the per-
iod between January 2004 and 1 October 2011.
Typing of isolates harbouring mecALGA251
The Danish isolates harbouring mecALGA251 could be grouped
into two MLST CCs, CC130 (n = 71) and CC1943 (n = 13).
Among the CC130 isolates, 12 different spa types were iden-
tified, dominated by t843 (n = 48). The remainder comprised
related spa types as follows: t528 (n = 7), t1535 (n = 3),
t1773 (n = 3), t1048 (n = 2), t3256 (n = 2), t1532, t1736,
t3218, t3570, t5970 and t9397. Among the CC1943 isolates,
t978 (n = 6) and the related t2345 (n = 4) and t3391
(n = 2), and a new spa type, t8835, were detected. Thirty-
three UK isolates and three French isolates belonged to
CC130 (t843, n = 24, t7485, n = 3; t1535 and t6293, n = 2
each; t6220, t6292, t7734, t7946 and t7947). Two UK iso-
lates belonged to CC1943 (t7945), and six English isolates
were related to a genetic lineage not found in Danish isolates
(CC425), with spa types t742 (n = 2), t6292 (n = 2), t6300,
and t6386. A subset of eight Danish strains were typed by
MLST from the two spa clusters, and confirmed the CC130
and CC1943 clustering.
The multiplex protocol was validated on 185 isolates: (i)
127 phenotypic MRSA isolates (mecA-negative and mecA/
mecALGA251-positive); (ii) 38 conventional MRSA isolates
(mecA-positive and mecALGA251-negative); and (iii) 20 MSSA
isolates (mecA/mecALGA251-negative). The sensitivity and speci-
ficity were 100% for identification of the three groups. Fur-
thermore, spa amplicons from isolates containing only one
spa repeat (t528) were distinguishable from both the mecA
and mecALGA251 PCR fragments when analysed by gel electro-
phoresis (Fig. 1).
In addition, direct sequencing of the spa PCR products
was not affected by the presence of the extra mecALGA251
amplicon in the sequencing reaction, and reliable spa
sequences were obtained.
Routine testing with the new multiplex PCR
Twelve isolates harbouring mecALGA251 were identified among
203 isolates submitted for genetic confirmation of MRSA
phenotype in a 2-month period. All were successfully spa-
typed with the new protocol, and this revealed no other spa
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types than those included in the initial validation set; t843
was predominant.
Sequence analysis of mecALGA251 and SCCmec
characterization
Sequence data from mecALGA251 (631 bp: positions 36 827–
36 197 of LGA251) from 79 isolates were analysed to inves-
tigate sequence variation of the gene, and aligned with ten
sequences of mecA representing all published SCCmec types
(data not shown). All mecALGA251 fragments clustered with
the LGA251 sequence. Only six single-nucleotide polymor-
phisms (SNPs) were observed among the mecALGA251 frag-
ments sequenced, including two silent third-base mutations
(pos. 36821 T>C; pos. 36235 C>T) and four conservative
missense mutations (Ala346Ser, Tyr363Phe, Arg466His, and
Asp482Asn). These SNPs did not correlate with spa types or
differences in ccr alleles.
Additional PCRs detecting mecI/mecR, ccrA/B and blaZ indi-
cated that mecALGA251 was contained within SCCmec type XI
elements. ccrA and ccrB amplifications were, however, not
obtained for eight CC130 isolates, and ccrB was not detected
in a further 18 isolates (16 CC130 and two CC1943) with
the primers of Garcia-Alvarez et al. The ccrA/B genes from
these 26 isolates were also not detected with primers
designed to detect other ccrAB allele variants [9], and no
correlation with specific spa types was observed (Table 2).
Discussion
Genotypic detection of mecA is widely used as a reference
standard for identification of MRSA, whether used as a pri-
mary test or for confirmation [10]. Phenotypically resistant
(cefoxitin/oxacillin) isolates that lack mecA when tested by
FIG. 1. Multiplex PCR for detection of mecA, mecALGA251, lukF-PV and
spa. Lanes 1 and 8: 100-bp ladder. Lane 2: LGA251 MRSA. Lane 3:
USA300 MRSA (PVL+). Lane 4: 73876 MRSA (t528 one spa repeat).
Lane 5: 72976 MRSA (t843). Lane 6: 8325-4 MSSA. Lane 7: H2O.
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PCR are often identified as borderline oxacillin-resistant
S. aureus (BORSA) or, more rarely, moderately resistant
S. aureus (MODSA) strains. Following the discovery of
mecALGA251, the main genetic basis for the MODSA MRSA
phenotype may have been resolved. Using the recently pub-
lished PCR detection assay [1] to confirm the presence of
mecALGA251, we analysed BORSA and MODSA isolates at the
national S. aureus reference laboratory in Denmark, as well
as isolates with spa types identical or similar to those of iso-
lates previously reported as being associated with the mecA
homologue. This revealed a total of 84 mecALGA251-positive
isolates, including the 24 reported recently [1].
On the basis of the complete genome sequence of S. aur-
eus LGA251 (GenBank accession number FR821779), Gar-
cia-Alvarez et al. designed a PCR to detect both mecA and
mecALGA251, resulting in a single undifferentiated amplicon. In
this study, a method was derived based on the LGA251
genome sequence to facilitate the detection and character-
ization of isolates harbouring mecALGA251 by expanding a
previously published multiplex PCR (targeting mecA, spa,
and lukF-PV) to include mecALGA251-specific primers. This
method showed 100% specificity and sensitivity for both
mecA targets when tested on 185 isolates. The PCR ampli-
cons were readily visualized by the use of agarose electro-
phoresis to identify the various combinations of detected
genes (Fig. 1). Sequencing of the spa PCR products was not
hindered by the extra mecALGA251 amplicon in the sequenc-
ing reaction.
We discovered a number of different spa types associated
with the two clonal lineages CC130 and CC1943, together
with two novel MLST types, both related to CC1943. The
characterization of the SCC elements in 79 isolates indicated
that mecALGA251 in all isolates was contained within an
SCCmec type XI element. However, some variation was
observed in the PCR results with regard to detection of the
ccrA/B alleles. On the basis of the other results indicating the
consistent presence of SCCmec type XI, we speculate that
the ccrA/B PCR-negative results are most likely to result
from minor sequence differences in the SCCmec type XI-
specific ccr alleles.
To investigate the sequence variation of mecALGA251,
sequence analysis was performed for a 631-bp fragment
(positions 36 827–36 197 of LGA251) from a total of 79 iso-
lates, including Danish, French and UK isolates to increase
the possible diversity. The analysis provides evidence indicat-
ing that mecALGA251 is highly conserved, thus supporting the
existence of a clearly distinct novel mecA homologue.
We identified six SNPs with no apparent impact on the
observed phenotypic resistance to cefoxitin, and that did not
correlate with spa types, or with differences in ccrA/B detec-
tion.
On the basis of 60 days of screening, the finding of 12
mecALGA251-positive isolates among 203 routine isolates pro-
vides evidence to suggest that mecALGA25 is potentially signifi-
cant for the occurrence of MRSA isolates in Denmark.
In conclusion, we present a technique that facilitates rapid
co-detection and differentiation of both mecA variants and
their Panton–Valentine leukocidin (PVL) locus together with
the ability to perform typing downstream by spa sequencing
to allow rapid and inexpensive typing and genetic clustering
of isolates. We also present the first evidence that
mecALGA251 is highly conserved, and that the corresponding
SCCmec elements show some variation in the ccrA/B regions
without any relation to specific spa types.
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